GP-2102

N/A

Report date: 2025/03/17 14:01:47
NME

Base Information

Drug NameGP-2102
Drug Alias NameGP-2102GP2102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAryl hydrocarbon receptor modulatorsHistamine H1 receptor modulatorsProtease-activated receptor-1 modulators
TargetsAryl hydrocarbon receptorHistamine H1 receptorProtease-activated receptor-1
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Gritpharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Gritpharma Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A